According to a report by Crypto Briefing, 21Shares has filed an S-1/A amendment registration for an Injective ETF, proposing to list it on Nasdaq under the trading symbol TINJ. The fund plans to use the FTSE Injective Index as its benchmark, track the performance of the INJ token, and, as appropriate, use a portion of its INJ holdings for staking to earn staking rewards. This amendment relates to the initial application submitted in October 2025; the product has not yet been approved for listing, and the custody arrangements are still pending final confirmation.